Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

Nuclear @ McMaster

New partnership builds pipeline for highly trained students mastering radiopharmaceuticals research for cancer treatment

John Valliant, Fusion Pharmaceuticals CEO and McMaster professor; Karen Mossman, vice-president, research; Dave Tucker, assistant vice-president research, nuclear; David Farrar, president and vice-chancellor; and Maureen MacDonald, dean, Faculty of Science at the partnership launch event.

Read more at Brighter World.

 Education,  Health,  News